Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Michel Lacroix is a pioneering neurosurgeon and researcher whose work sits at the intersection of advanced surgical technology and epilepsy treatment. His primary research areas include minimally invasive neurosurgery, laser interstitial thermal therapy (LITT), and the integration of novel antimitotic therapies with radiation oncology. Dr. Lacroix’s most significant contribution is his landmark 2025 study on LITT for mesial temporal lobe epilepsy (MTLE), which has already garnered 9 citations—a remarkable achievement for a recent publication. This work provides critical insights into seizure outcomes and procedural safety, establishing LITT as a viable, less invasive alternative to traditional open surgery for drug-resistant epilepsy. Additionally, his 2021 investigation into targeting accuracy during concurrent Tumor Treating Fields (TTFields) therapy and robotic hypofractionated radiation therapy for glioblastoma demonstrates his forward-thinking approach to multimodal cancer treatment. By addressing the technical challenges of combining these therapies, Dr. Lacroix has laid crucial groundwork for improving outcomes in aggressive brain tumors. His research is essential reading for clinicians and scientists seeking to understand the future of precision, minimally invasive interventions in neuro-oncology and epilepsy surgery.